A second booster dose resulted in 123,869 fewer hospitalizations and 5,524 fewer deaths versus a single-dose campaign.
No elevated risk for stroke seen after COVID-19 bivalent vaccine receipt
Mar 20, 2024
No evidence was seen for an increased risk for stroke in one- to 21-day or 22- to 42-day windows compared with a 43- to 90-day window after the vaccine.
COVID-19 vaccination linked to lower risk for postinfection outcomes
Mar 13, 2024
A reduced risk was seen for venous thromboembolism, arterial thrombosis/thromboembolism and heart failure.
Bivalent COVID-19 shot effective for preventing thromboembolic events
Jan 11, 2024
The findings were seen for adults aged 65 years and older and for those aged 18 years and older with end-stage renal disease.
Fourth COVID-19 shot beneficial in patients with autoimmune rheumatic diseases
Nov 28, 2023
A fourth dose reduces the risk for SARS-CoV-2 for patients with systemic autoimmune rheumatic diseases using DMARDs.
COVID-19 vaccination before infection cuts risk for long COVID
Nov 27, 2023
COVID-19 vaccination with any number of doses before infection was linked to a reduced risk for post-COVID-19 condition.
More than 7 million Americans have gotten the new COVID-19 vaccines
Oct 13, 2023
Approximately 91% of Americans ages 12 years and older can now get the vaccines within five miles of home, as 14 million doses have been shipped.
COVID-19 infection, vaccination have little effect on migraine worsening
Oct 04, 2023
An increased concern about migraine worsening was a risk factor for perceived migraine worsening.
FDA approves updated Novavax COVID-19 vaccine
Oct 04, 2023
The updated shot is expected to better target variants that are circulating now and help prevent hospitalization and death from the virus.
Just 23 percent of US adults ‘definitely’ plan to get new COVID-19 vaccine
Sep 27, 2023
Interest is highest among those aged 65 years and older (64%) and among Democrats (70%).